Literature DB >> 24681157

The effect of diet on the protective action of D156844 observed in spinal muscular atrophy mice.

Matthew E R Butchbach1, Jasbir Singh2, Mark E Gurney3, Arthur H M Burghes4.   

Abstract

Spinal muscular atrophy (SMA) is an early-onset motor neuron disease characterized by loss of spinal motor neurons which leads to skeletal muscle atrophy. Proximal SMA results from the loss or mutation of the survival motor neuron (SMN) gene. In humans, the SMN gene is duplicated to produce two nearly identical genes, SMN1 and SMN2. SMN1 is lost in SMA but SMN2 is retained; in fact, the number of SMN2 copies correlates with disease severity. The SMN2 inducer D156844 increases the survival and improves phenotype of SMN∆7 SMA mice. Maternal diet also modifies the survival and phenotype of these mice. In this study, we show the effect of maternal diet on the protective effects of D156844 in SMN∆7 SMA mice. SMA mice maintained on the PicoLab20 Mouse diet survived longer when treated with D156844; the effect of diet was additive to the effect of D156844 on these mice. Brain levels of D156844 were higher in neonatal mice maintained on the PicoLab20 diet than those on the Harlan-Teklad 22/5 diet. SMN protein levels in the spinal cord were modestly elevated in D156844-treated, PicoLab20-maintained SMA mice. These data show that maternal diet does influence the responsiveness of D156844 in neonatal SMN∆7 SMA mice.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2,4-Diaminoquinazoline; Maternal diet; Motor neuron disease; Neonatal mouse; Preclinical drug trial; Spinal muscular atrophy

Mesh:

Substances:

Year:  2014        PMID: 24681157      PMCID: PMC4029929          DOI: 10.1016/j.expneurol.2014.03.005

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  38 in total

1.  The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.

Authors:  U R Monani; M Sendtner; D D Coovert; D W Parsons; C Andreassi; T T Le; S Jablonka; B Schrank; W Rossoll; W Rossol; T W Prior; G E Morris; A H Burghes
Journal:  Hum Mol Genet       Date:  2000-02-12       Impact factor: 6.150

2.  Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy.

Authors:  Monir Shababi; Javad Habibi; Lixin Ma; Jacqueline J Glascock; James R Sowers; Christian L Lorson
Journal:  J Mol Cell Cardiol       Date:  2012-01-17       Impact factor: 5.000

3.  A mouse model for spinal muscular atrophy.

Authors:  H M Hsieh-Li; J G Chang; Y J Jong; M H Wu; N M Wang; C H Tsai; H Li
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

Review 4.  Influence of food and diet on gastrointestinal drug absorption: a review.

Authors:  P G Welling
Journal:  J Pharmacokinet Biopharm       Date:  1977-08

5.  Physical exercise reduces cardiac defects in type 2 spinal muscular atrophy-like mice.

Authors:  Olivier Biondi; Philippe Lopes; Céline Desseille; Julien Branchu; Farah Chali; Amina Ben Salah; Claude Pariset; Christophe Chanoine; Frédéric Charbonnier
Journal:  J Physiol       Date:  2012-08-28       Impact factor: 5.182

6.  Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model.

Authors:  Luc Dupuis; Hugues Oudart; Frédérique René; Jose-Luis Gonzalez de Aguilar; Jean-Philippe Loeffler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

7.  Glucose metabolism and pancreatic defects in spinal muscular atrophy.

Authors:  Melissa Bowerman; Kathryn J Swoboda; John-Paul Michalski; Gen-Sheng Wang; Courtney Reeks; Ariane Beauvais; Kelley Murphy; John Woulfe; Robert A Screaton; Fraser W Scott; Rashmi Kothary
Journal:  Ann Neurol       Date:  2012-08       Impact factor: 10.422

8.  The DcpS inhibitor RG3039 improves survival, function and motor unit pathologies in two SMA mouse models.

Authors:  Rocky G Gogliotti; Herminio Cardona; Jasbir Singh; Sophie Bail; Carina Emery; Nancy Kuntz; Michael Jorgensen; Madel Durens; Bing Xia; Courtenay Barlow; Christopher R Heier; Heather L Plasterer; Vincent Jacques; Megerditch Kiledjian; Jill Jarecki; James Rusche; Christine J DiDonato
Journal:  Hum Mol Genet       Date:  2013-06-04       Impact factor: 6.150

9.  The DcpS inhibitor RG3039 improves motor function in SMA mice.

Authors:  James P Van Meerbeke; Rebecca M Gibbs; Heather L Plasterer; Wenyan Miao; Zhihua Feng; Ming-Yi Lin; Agnieszka A Rucki; Claribel D Wee; Bing Xia; Shefali Sharma; Vincent Jacques; Darrick K Li; Livio Pellizzoni; James R Rusche; Chien-Ping Ko; Charlotte J Sumner
Journal:  Hum Mol Genet       Date:  2013-05-31       Impact factor: 6.150

10.  A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy.

Authors:  Umrao R Monani; Matthew T Pastore; Tatiana O Gavrilina; Sibylle Jablonka; Thanh T Le; Catia Andreassi; Jennifer M DiCocco; Christian Lorson; Elliot J Androphy; Michael Sendtner; Michael Podell; Arthur H M Burghes
Journal:  J Cell Biol       Date:  2003-01-06       Impact factor: 10.539

View more
  8 in total

1.  Protective effects of butyrate-based compounds on a mouse model for spinal muscular atrophy.

Authors:  Matthew E R Butchbach; Casey J Lumpkin; Ashlee W Harris; Luciano Saieva; Jonathan D Edwards; Eileen Workman; Louise R Simard; Livio Pellizzoni; Arthur H M Burghes
Journal:  Exp Neurol       Date:  2016-02-15       Impact factor: 5.330

2.  The effect of the DcpS inhibitor D156844 on the protective action of follistatin in mice with spinal muscular atrophy.

Authors:  Ashlee W Harris; Matthew E R Butchbach
Journal:  Neuromuscul Disord       Date:  2015-05-27       Impact factor: 4.296

3.  Effect of the Butyrate Prodrug Pivaloyloxymethyl Butyrate (AN9) on a Mouse Model for Spinal Muscular Atrophy.

Authors:  Jonathan D Edwards; Matthew E R Butchbach
Journal:  J Neuromuscul Dis       Date:  2016-11-29

Review 4.  Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis.

Authors:  Andrew P Tosolini; James N Sleigh
Journal:  Front Mol Neurosci       Date:  2017-12-07       Impact factor: 5.639

5.  The effects of C5-substituted 2,4-diaminoquinazolines on selected transcript expression in spinal muscular atrophy cells.

Authors:  Cinsley Gentillon; Andrew J Connell; Ryan W Kirk; Matthew E R Butchbach
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

6.  Brain microvasculature defects and Glut1 deficiency syndrome averted by early repletion of the glucose transporter-1 protein.

Authors:  Maoxue Tang; Guangping Gao; Carlos B Rueda; Hang Yu; David N Thibodeaux; Tomoyuki Awano; Kristin M Engelstad; Maria-Jose Sanchez-Quintero; Hong Yang; Fanghua Li; Huapeng Li; Qin Su; Kara E Shetler; Lynne Jones; Ryan Seo; Jonathan McConathy; Elizabeth M Hillman; Jeffrey L Noebels; Darryl C De Vivo; Umrao R Monani
Journal:  Nat Commun       Date:  2017-01-20       Impact factor: 14.919

7.  Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy Mice.

Authors:  Lisa M Walter; Marc-Olivier Deguise; Katharina E Meijboom; Corinne A Betts; Nina Ahlskog; Tirsa L E van Westering; Gareth Hazell; Emily McFall; Anna Kordala; Suzan M Hammond; Frank Abendroth; Lyndsay M Murray; Hannah K Shorrock; Domenick A Prosdocimo; Saptarsi M Haldar; Mukesh K Jain; Thomas H Gillingwater; Peter Claus; Rashmi Kothary; Matthew J A Wood; Melissa Bowerman
Journal:  EBioMedicine       Date:  2018-05-04       Impact factor: 8.143

Review 8.  Metabolic and Nutritional Issues Associated with Spinal Muscular Atrophy.

Authors:  Yang-Jean Li; Tai-Heng Chen; Yan-Zhang Wu; Yung-Hao Tseng
Journal:  Nutrients       Date:  2020-12-16       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.